CIN gene therapy (Transgenex Nanobiotech)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameCIN gene therapy (Transgenex Nanobiotech)
Drug Alias Namechitosan/IFN-gamma-pDNA nanoparticle gene therapy (Transgenex Nanobiotech)
ClassificationBiologics
Mechanisms of ActionInterferon gamma receptor stimulants
TargetsInterferon gamma receptor
Therapy Area/IndicationsAsthma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesTransGenex Nanobiotech Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesTransGenex Nanobiotech Inc
Active IndicationsN/A
Inactive IndicationsAsthma

Other Information

ATC CodeN/A
Related LinksN/A